Potential application areas: Coronary artery disease (CAD), cerebrovascular disease (stroke), cardiomyopathy, congestive heart failure, acute coronary syndrome, atherosclerosis, etc.

Cardiovascular disease (CVD) is a multifactorial disease that results in abnormal cardiovascular function. While a diverse set of mechanisms contribute to CVD, inflammatory and metabolic pathways are known to play key roles in the development of hallmark symptoms including hypoxia, artery thickening, blood vessel damage, and the resulting heart muscle damage.

Therapy Indication Analyte button Product Associations

Below is a list of blood-based protein biomarkers in our menu that have demonstrated links to cardiovascular disease in the scientific literature. The products listed here may also contain biomarkers useful in cardiovascular research.

Click or mouse over biomarkers for more information

1. Adiponectin 2. Angiopoietin-1
3. Angiopoietin-2 4. Angiopoietin-related protein 3
5. Angiotensin-Converting Enzyme 6. Angiotensinogen
7. Antithrombin-III 8. Apolipoprotein A-I
9. Apolipoprotein A-II 10. Apolipoprotein B
11. Apolipoprotein C-III 12. Apolipoprotein E
13. Apolipoprotein H 14. Apolipoprotein(a)
15. C-Reactive Protein 16. Carcinoembryonic antigen-related cell adhesion molecule 1
17. CD163 18. Complement C3 alpha des arg
19. Connective Tissue Growth Factor 20. Creatine Kinase-MB
21. Cystatin-C 22. Endoglin
23. Endostatin 24. Endothelin-1
25. Epiregulin 26. Factor VII
27. Fatty Acid-Binding Protein, adipocyte 28. Fatty Acid-Binding Protein, liver
29. Fibrinogen 30. Fibroblast Growth Factor 4
31. Fibroblast Growth Factor basic 32. Galectin-3
33. Gelsolin 34. Glucose-6-phosphate Isomerase
35. Glutamate-Cysteine Ligase Regulatory subunit 36. Glycogen phosphorylase isoenzyme BB
37. Granulocyte Colony-Stimulating Factor 38. Growth-Regulated alpha protein
39. Growth/differentiation factor 15 40. Haptoglobin
41. Heparin-Binding EGF-Like Growth Factor 42. Intercellular Adhesion Molecule 1
43. Interferon gamma 44. Interferon gamma Induced Protein 10
45. Interleukin-1 alpha 46. Interleukin-1 beta
47. Interleukin-10 48. Interleukin-18
49. Interleukin-6 50. Interleukin-6 receptor
51. Interleukin-8 52. Lectin-Like Oxidized LDL Receptor 1
53. Leptin 54. Low Density Lipoprotein Cholesterol
55. Macrophage-Derived Chemokine 56. Malondialdehyde-Modified Low-Density Lipoprotein
57. Matrix Metalloproteinase-2 58. Matrix Metalloproteinase-3
59. Matrix Metalloproteinase-9 60. Methylglyoxal
61. Monocyte Chemotactic Protein 1 62. Myeloperoxidase
63. Myoglobin 64. N-terminal prohormone of brain natriuretic peptide
65. Nerve Growth Factor beta 66. Neuropilin-1
67. Osteopontin 68. Osteoprotegerin
69. Paraoxonase-1 70. Pigment Epithelium Derived Factor
71. Placenta Growth Factor 72. Plasminogen Activator Inhibitor 1
73. Platelet endothelial cell adhesion molecule 74. Platelet-Derived Growth Factor BB
75. Pregnancy-Associated Plasma Protein A 76. Pulmonary and Activation-Regulated Chemokine
77. Receptor for advanced glycosylation end products 78. Serotransferrin
79. Serum Amyloid A Protein 80. Serum Amyloid P-Component
81. Serum Glutamic Oxaloacetic Transaminase 82. Sex Hormone-Binding Globulin
83. Sortilin 84. ST2
85. Stromal Cell-Derived Factor-1 alpha 86. Thrombomodulin
87. Thrombospondin-1 88. Tissue Factor
89. Tissue Inhibitor of Metalloproteinases 1 90. Tissue Inhibitor of Metalloproteinases 2
91. Tissue type Plasminogen activator 92. Tumor Necrosis Factor alpha
93. Tumor necrosis factor ligand superfamily member 12 94. Tumor necrosis factor ligand superfamily member 13
95. Tyrosine kinase with Ig and EGF homology domains 1 96. Tyrosine kinase with Ig and EGF homology domains 2
97. Vascular Cell Adhesion Molecule-1 98. Vascular Endothelial Growth Factor
99. Vascular endothelial growth factor B 100. Vascular Endothelial Growth Factor C
101. Vascular endothelial growth factor D 102. Vascular Endothelial Growth Factor Receptor 1
103. Vascular Endothelial Growth Factor Receptor 2 104. Vascular endothelial growth factor receptor 3
105. Vitamin K-Dependent Protein S 106. von Willebrand Factor